Evidence map›Paper›PMID 42370475›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2026

ROS-Balancing MXene/MoSe

Xiangnan Zhang, Wenxuan He, Yujie Zhou, Hao Yang, Shuangquan Lai, Xiang Wen, Yi Deng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiangnan ZhangSchool of Chemical Engineering, Sichuan University, Chengdu, China.
Wenxuan HeSchool of Chemical Engineering, Sichuan University, Chengdu, China.
Yujie ZhouResearch Center for Nano-Biomaterials & Regenerative Medicine, Department of Biomedical Engineering, College of Artificial Intelligence, Taiyuan University of Technology, Taiyuan, China.
Hao YangSchool of Chemical Engineering, Sichuan University, Chengdu, China.
Shuangquan LaiSchool of Chemical Engineering, Sichuan University, Chengdu, China.ORCID 0009-0009-7150-8868
Xiang WenDepartment of Dermatology, West China Hospital, Sichuan University, Chengdu, China.
Yi DengSchool of Chemical Engineering, Sichuan University, Chengdu, China.ORCID 0000-0002-1765-5244

Funding

National Natural Science Foundation of China 32271392National Natural Science Foundation of China 32571536Natural Science Foundation of Sichuan Province 2024NSFSC0676Science &Technology Department of Sichuan Province 2025ZNSFSC0597Sichuan International Science and Technology Innovation Cooperation Project 2026YFHZ0080Sichuan University Zigong Science and Technology Cooperation Funding 2024CDZG-24
6 · The paper itself

Abstract

Multidrug-resistant (MDR) bacterial infections and persistent oxidative stress exert a prolonged, hostile inflammatory pressure in chronic skin wounds, posing a formidable clinical challenge. Current antibiotic-based modalities often fall short in inflammation resolution and cutaneous regeneration. Here, we present the design of a reactive oxygen species (ROS)-balancing MXene/MoSe

Indexed as

Reactive Oxygen SpeciesRegenerationSkinWound HealingAnimalsAnti-Bacterial AgentsMethicillin-Resistant Staphylococcus aureusNitritesOxidative StressTransition ElementsAnti-Bacterial AgentsMXeneNitritesReactive Oxygen SpeciesTransition Elementsbacterial respiratory chaininfected woundsmultidrug‐resistant bacteriaROS‐balancingsonodynamic therapy

Identifiers

PMID42370475
PMCPMC13485034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.